Peroxisome Proliferator-Activated Receptor γ Activity is Required for Appropriate Cardiomyocyte Differentiation
暂无分享,去创建一个
[1] Jin Han,et al. The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action , 2012, Pflügers Archiv - European Journal of Physiology.
[2] A. Lazou,et al. PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt. , 2012, Canadian journal of physiology and pharmacology.
[3] Hananeh Fonoudi,et al. ESC Cardiac Differentiation and Applications , 2011 .
[4] C. Atwood. Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis , 2011 .
[5] H. Baharvand,et al. The expression of peroxisomal protein transcripts increased by retinoic acid during neural differentiation. , 2011, Differentiation; research in biological diversity.
[6] K. Segawa,et al. Pretreatment of Human Mesenchymal Stem Cells with Pioglitazone Improved Efficiency of Cardiomyogenic Transdifferentiation and Cardiac Function , 2011, Stem cells.
[7] E. Blasi,et al. Effects of Chronic PPAR-Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague-Dawley Rats , 2009, PPAR research.
[8] M. Benderitter,et al. Reduction of Peroxisome Proliferation-Activated Receptor γ Expression by γ-Irradiation as a Mechanism Contributing to Inflammatory Response in Rat Colon: Modulation by the 5-Aminosalicylic Acid Agonist , 2008, Journal of Pharmacology and Experimental Therapeutics.
[9] M. Wartenberg,et al. Peroxisome Proliferator‐Activated Receptor α Agonists Enhance Cardiomyogenesis of Mouse ES Cells by Utilization of a Reactive Oxygen Species‐Dependent Mechanism , 2008, Stem cells.
[10] Y. Lou,et al. Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor α inhibitor GW6471 in murine embryonic stem cells in vitro , 2007, Acta Pharmacologica Sinica.
[11] B. Brüne,et al. PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages , 2007, The Journal of cell biology.
[12] B. Finck,et al. The PPAR regulatory system in cardiac physiology and disease. , 2007, Cardiovascular research.
[13] E. Olson,et al. A Common Progenitor at the Heart of Development , 2006, Cell.
[14] D. Clapham,et al. In Brief , 2006, Nature Reviews Drug Discovery.
[15] Yunfu Sun,et al. Multipotent Embryonic Isl1 + Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification , 2006, Cell.
[16] S. Kattman,et al. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. , 2006, Developmental cell.
[17] N. Patel,et al. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. , 2005, Kidney international.
[18] K. Boheler,et al. Embryonic stem cells: prospects for developmental biology and cell therapy. , 2005, Physiological reviews.
[19] H. Baharvand,et al. Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains , 2004, In Vitro Cellular & Developmental Biology - Animal.
[20] T. Thalhammer,et al. The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[21] T. Willson,et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. , 2002, Biochemistry.
[22] W. Wahli,et al. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. , 2000, Mutation research.
[23] K. Boheler,et al. Embryonic Stem Cells as a Developmental Model in vitro , 1999 .
[24] M. Nasr-Esfahani,et al. The influence of peroxisome proliferator-activated receptor γ(1) during differentiation of mouse embryonic stem cells to neural cells. , 2012, Differentiation; research in biological diversity.
[25] S. Homma,et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. , 2007, The Journal of clinical investigation.
[26] T. Thatcher,et al. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[27] J. Lehmann,et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.